Trinity Biotech (TRIB) Launches New Subsidiary Trinovium Today

AI Summary

Trinity Biotech (TRIB) has officially launched its new subsidiary, Trinovium, aimed at developing liquid cooling solutions. The establishment of Trinovium is part of TRIB's strategy to expand its product offerings within technology markets. The launch marks a significant step in TRIB's diversification efforts. Details regarding potential financial impacts or specific market entry targets have not been disclosed.